MitraClip is ideal for patients with moderate to severe mitral regurgitation who are not suitable for open-heart surgery due to age, frailty, or other medical conditions.

Yes, MitraClip is considered a safe alternative to surgery, especially for high-risk patients. It has been used successfully in thousands of patients worldwide with a good safety profile.

The procedure typically takes 1–3 hours. It is performed under general anesthesia and guided by imaging to ensure accurate placement of the clip.

Recovery is usually quick. Most patients stay in the hospital for 1–3 days and resume normal activities within a week, much faster than traditional heart surgery.

Many patients experience symptom relief—such as reduced shortness of breath and fatigue—within days or weeks, allowing them to return to everyday activities with improved quality of life.

The MitraClip is designed to be a long-term solution. Clinical studies show it remains effective for years, but regular follow-up with your heart doctor is important to monitor your condition.

While rare, risks can include bleeding, infection, or complications from anesthesia. Your cardiologist will explain these risks and ensure the benefits outweigh them in your case.

Yes, you may need to take medications like blood thinners or antiplatelets for a short period after the procedure. Your doctor will tailor the treatment plan to your needs.

Your care team will guide you through any required tests and fasting instructions before the procedure. It’s important to discuss all medications and follow pre-procedure guidelines closely.